The Insulin in Dosage market in Greece saw a significant fluctuation from 2013 to 2023. Initially, the market size experienced a decline, with values dropping from $234.93 million in 2013 to $201.51 million in 2017. However, the market began to recover in 2018, witnessing a series of year-on-year increases. By 2023, the value had risen to $290.11 million. In the last two years, the market grew by 6.17% in 2022 and 5.75% in 2023. Over the past five years, the Compound Annual Growth Rate (CAGR) was 6.69%, indicating a steady upward trend.
Future trends to watch for include advancements in insulin technology, government policies affecting healthcare, and the growing prevalence of diabetes, which could drive further market expansion. Monitoring these factors is crucial for understanding the market's direction and potential opportunities.
How does Greece rank in Insulin in Dosage Market Size Value?
| # | 24 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 China | 5,142,200,000 | 2023 | +4.22% | +3.16% | View data |
| 2 | 2 Germany | 2,490,600,000 | 2023 | -2.64% | -0.27% | View data |
| 3 | 3 United Kingdom | 1,864,000,000 | 2023 | +0.081% | +0.91% | View data |
| 4 | 4 Canada | 1,369,700,000 | 2023 | +1.89% | +2.55% | View data |
| 5 | 5 Japan | 1,340,600,000 | 2023 | -14.34% | -8.01% | View data |
| 10 | 10 Czech Republic | 331,020,000 | 2023 | +1.22% | +0.83% | View data |
| 11 | 11 Poland | 308,530,000 | 2023 | -3.91% | -4.34% | View data |
| 12 | 12 Greece | 290,110,000 | 2023 | +5.75% | +6.69% | |
| 13 | 13 Belgium | 260,730,000 | 2023 | +2.7% | +3.78% | View data |
| 14 | 14 South Africa | 196,340,000 | 2023 | +0.82% | +0.56% | View data |
